Institutional Ownership
Qualigen Therapeutics Inc
CUSIP 74754R301COMAIXCQ1 2026
Institutional Holders
11
13F filers
Shares Held
95.8K
Aggregate institutional
Institutional Value
$119.8K
Q1 2026
Net New Holders
-3
3 new · 6 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions3
Increased2
Decreased0
Sold out6
Institutional Holders
11 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 70.5K | $88.1K | +57.8K | Added |
| 2 | Two Sigma Securities, LLC | 13.5K | $16.9K | +13.5K | New |
| 3 | Goldman Sachs Group Inc | 10.8K | $13.5K | +10.8K | New |
| 4 | Blackrock, Inc. | 501 | $626 | 0 | Held |
| 5 | Harbour Investments, Inc. | 325 | $406 | 0 | Held |
| 6 | Highmark Wealth Management LLC | 160 | $200 | 0 | Held |
| 7 | Group One Trading LLC | 8 | $10 | 0 | Held |
| 8 | Sbi Securities Co., Ltd. | 6 | $8 | +5 | Added |
| 9 | Physician Wealth Advisors, Inc. | 2 | $3 | 0 | Held |
| 10 | Danske Bank A/S | 1 | $1 | 0 | Held |
1 more institutional holders on Premium
See every fund holding Qualigen Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders